Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer

被引：0

作者：

Okamoto, W. ^{[1
]}

Nakamura, Y. ^{[2
]}

Shiozawa, M. ^{[3
]}

Komatsu, Y. ^{[4
]}

Denda, T. ^{[5
]}

Hara, H. ^{[6
]}

Kagawa, Y. ^{[7
]}

Narita, Y. ^{[8
]}

Kawakami, H. ^{[9
]}

Esaki, T. ^{[10
]}

Nishina, T. ^{[11
]}

Izawa, N. ^{[12
]}

Ando, K. ^{[13
]}

Moriwaki, T. ^{[14
]}

Kato, T. ^{[15
]}

Nagashima, F. ^{[16
]}

Satoh, T. ^{[17
]}

Nomura, S. ^{[18
]}

Yoshino, T. ^{[2
]}

Akagi, K. ^{[19
]}

机构：

[1] Hiroshima Univ Hosp, Canc Treatment Ctr, Hiroshima, Japan

[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[3] Kanagawa Canc Ctr, Gastrointestinal Surg, Yokohama, Kanagawa, Japan

[4] Hokkaido Univ Hosp, Dept Canc Chemotherapy, Canc Ctr, Sapporo, Hokkaido, Japan

[5] Chiba Canc Ctr Hosp, Div Gastroenterol, Chiba, Japan

[6] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan

[7] Kansai Rosai Hosp, Surg, Amagasaki, Hyogo, Japan

[8] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[9] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan

[10] Natl Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Fukuoka, Japan

[11] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan

[12] St Marianna Univ, Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan

[13] Kyushu Univ, Surg & Sci, Fukuoka, Fukuoka, Japan

[14] Univ Tsukuba, Gastroenterol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Osaka Natl Hosp, Dept Surg, Osaka, Japan

[16] Kyorin Univ Hosp, Med Oncol, Tokyo, Japan

[17] Osaka Univ, Fac Med, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan

[18] Natl Canc Ctr Hosp East, Clin Res Support Off, Kashiwa, Chiba, Japan

[19] Saitama Canc Ctr, Mol Diag & Canc Prevent, Saitama, Japan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

614P

引用

下载

页数：2

共 50 条

[41] Mucinous Colorectal Cancer is Associated With Expression of the TIM-3 Immune Checkpoint Independently of Microsatellite Instability (MSI) Status
Emer O’Connell
Manuela Salvucci
Ian S. Reynolds
Deborah A. McNamara
John P. Burke
Jochen H. M. Prehn
Annals of Surgical Oncology, 2021, 28 : 7999 - 8006
[42] Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability- high metastatic colorectal cancer treated with immune checkpoint inhibitors
Manca, Paolo
Corti, Francesca
Intini, Rossana
Mazzoli, Giacomo
Miceli, Rosalba
Germani, Marco Maria
Bergamo, Francesca
Ambrosini, Margherita
Cristarella, Eleonora
Cerantola, Riccardo
Boccaccio, Chiara
Ricagno, Gianmarco
Ghelardi, Filippo
Randon, Giovanni
Leoncini, Giuseppe
Milione, Massimo
Fassan, Matteo
Cremolini, Chiara
Lonardi, Sara
Pietrantonio, Filippo
EUROPEAN JOURNAL OF CANCER, 2023, 187 : 15 - 24
[43] Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Fuca, Giovanni
Corti, Francesca
Ambrosini, Margherita
Intini, Rossana
Salati, Massimiliano
Fenocchio, Elisabetta
Manca, Paolo
Manai, Chiara
Daniel, Francesca
Raimondi, Alessandra
Morano, Federica
Corallo, Salvatore
Prisciandaro, Michele
Spallanzani, Andrea
Quara, Virginia
Belli, Carmen
Vaiani, Marta
Curigliano, Giuseppe
Cremolini, Chiara
De Braud, Filippo
Di Bartolomeo, Maria
Zagonel, Vittorina
Lonardi, Sara
Pietrantonio, Filippo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
[44] Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond
Cohen, Romain
Rousseau, Benoit
Vidal, Joana
Colle, Raphael
Diaz, Luis A., Jr.
Andre, Thierry
TARGETED ONCOLOGY, 2020, 15 (01) : 11 - 24
[45] Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update
Boukouris, Aristeidis E.
Theochari, Maria
Stefanou, Dimitra
Papalambros, Alexandros
Felekouras, Evangelos
Gogas, Helen
Ziogas, Dimitrios C.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 173
[46] Applicability of the LIPI score to metastatic microsatellite instability high cancer patients treated with immune checkpoint inhibitors
Vuagnat, P.
Auclin, E.
Mezquita, L.
Adeva Alfonso, J.
Vidal Tocino, M. R.
Longo Munoz, F.
El Dakdouki, Y.
Romano, P. Martin
Baldini, C.
Varga, A.
Garcia-Carbonero, R.
Besse, B.
Massard, C.
Hollebecque, A.
ANNALS OF ONCOLOGY, 2019, 30 : 20 - 20
[47] Synergistic Effects of Fruquintinib Combined with Immune Checkpoint Inhibitors on Metastatic Colorectal Cancer
Xie, Ming-zhi
Li, Yong-qiang
Liang, Rong
Huang, Shi-ying
Qin, Shan-yu
Hu, Bang-li
JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (04) : 1620 - 1627
[48] Comparative analysis of the tumor immune microenvironment (TIME) in primary and metastatic sites of microsatellite stable (MSS) and microsatellite instability-high (MSI) colorectal cancer
Fakih, M.
Ye, J.
Wang, C.
Egelston, C.
Huang, M.
Mercer, J.
Thompson, M. A.
Gong, J.
ANNALS OF ONCOLOGY, 2023, 34 : S422 - S422
[49] Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond
Romain Cohen
Benoît Rousseau
Joana Vidal
Raphaël Colle
Luis A. Diaz
Thierry André
Targeted Oncology, 2020, 15 : 11 - 24
[50] Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors
Lengyel, Csongor Gyoergy
CURRENT DRUG TARGETS, 2021, 22 (09) : 968 - 976

← 1 2 3 4 5 →